Reach Us +44-1522-440391
A Proteomic Analysis with Suggested Applications in Amyloidotic Diseases | OMICS International
ISSN: 2155-9538
Journal of Bioengineering & Biomedical Science

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

A Proteomic Analysis with Suggested Applications in Amyloidotic Diseases

Vieira Amandio*

Biomedical Physiology BPK, Simon Fraser University, Burnaby, Canada

*Corresponding Author:
Vieira A
Biomedical Physiology BPK
Simon Fraser University
Burnaby, Canada
E-mail: [email protected]

Received Date: June 19, 2013; Accepted Date: June 20, 2013; Published Date: June 22, 2013

Citation: Amandio V (2013) A Proteomic Analysis with Suggested Applications in Amyloidotic Diseases. J Bioeng Biomed Sci 3: e117. doi: 10.4172/2155-9538.1000e117

Copyright: © 2013 Amandio V. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Bioengineering & Biomedical Science

Misfolded, aggregated proteins (agP) and peptides contribute to Alzheimer’s, Parkinson’s, and several other, lesser-known or less common, amyloidotic diseases. Table 1 lists some of these diseases and the associated agP or peptide; over 20 of these agP/peptides and related amyloidotic diseases are known. There is much interest in identifying the molecular and cellular toxicity mechanisms of these misfolded monomeric, oligomeric, and fibrillar forms. Mutant forms of an amyloidotic polypeptide may greatly increase its amyloidogenicity; but some mutant form may have greater stability and lower amyloidogenicity.

Disease Protein/peptide
Alzheimer’s disease Amyloid beta
Parkinson’s disease Alpha-synuclein
BSE and other encephalopathies Prions
Familial visceral amyloidosis Apolipoprotein AI
Familial amyloidotic polyneuropathy Transthyretin
Type 2 diabetes (pancreatic deposition in some cases) Amylin
Dialysis-related amyloidosis Beta 2-microglobulin

Table 1: List of some amyloidotic diseases and the main polypeptides involved.

We have begun to analyze the primary structure of wild-type and mutant forms of amyloidogenic proteins such as transthyretin, apolipoprotein A1, and others in an attempt to correlate structural changes with disease severity. For example, amino acid biophysical properties such as hydrophobicity scores can be incorporated into a moving average ‘window’, e.g., nine amino acid units, and used to scan across the whole protein sequence. Figure 1 shows a plot of such a moving average as a structural representation of a protein.


Figure 1: Example of a plot of a moving average amino acid score using a nine amino acid window.

The region around an amino acid mutation may differ between the wild-type and mutant, as shown in Figure 2, and the difference can be quantified using the areas under the curves (AUC). By using standards such as a mutation that is known to drastically change protein structure or is known to cause a severe form of disease, an optimization protocol can be developed to formulate the combination of amino acid biophysical properties which yield the greatest difference in AUC relative to the wild-type protein. Additional mathematical methods may useful in analyzing the plots. Amino acid scores that may be integrated into an optimal score formula include size, charge, secondary structure frequencies, hydrophobicity, surface free energy, etc. And optimization may include factoring in the properties of the most frequent substitutions for a given amino acid. In conclusion, these analyses based on readily available amino acid sequences may be useful in terms of predicting some higher-level protein structural changes, and perhaps disease severity of some mutant forms.


Figure 2: Hypothetical example of a plot of a moving average amino acid score to illustrate putative mutant effects (solid line, shaded area) of two different mutations, shown relative to the wild-type sequence (dashed line). For each mutant, the plot outside the region of the mutation would be identical to wildtype. The spread of such a region is directly proportional to the amino acidwindow size selected.

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 12169
  • [From(publication date):
    May-2013 - Aug 24, 2019]
  • Breakdown by view type
  • HTML page views : 8373
  • PDF downloads : 3796